March 3, 2009 
People are always surprised when I point out that 50% of generics are made by brand manufacturers. And, the company that has been most aggressive against generics – Pfizer – has recently made several deals to strengthen their generic subsidiary – Greenstone.
Leave a comment
Share This
My LinkedIn Profile
WSJ Health Blog
- Is a Paleo Diet Healthier Than Standard Nutritional Guidelines?
- Small Business and the Affordable Care Act: How Has Your Business Been Affected?
- HealthCare.gov Explorer: Decode the Health Law’s Subsidies
- One Reporter, Four Families, Six Scientists and the Search to Cure a Rare Disease
- Your Responses: How Has the Health Law Affected You?
- What Does the Health Law Mean for You? Your Questions Answered
- How Has the Health Law Affected You?
- Rare Diseases and the Search for a Cure: A Reddit AMA
- Robots to Cure Rare Diseases: A Reddit Ask Me Anything (AMA)
- Six Tips For Better Napping
Drug Channels
- The Hidden Costs of Over-Customizing Your Hub Technology Stack
- Specialty Pharmacy Accreditation: DCI’s Exclusive Analysis Reveals a Market at an Inflection Point
- Where Gross-to-net Pressure Actually Lives After Launch
- Drug Channels News Roundup, April 2026: PBM Specialty Pharmacy Steering, MLR Profit Shifting, Hospitals’ Fake Prices, and a Peek Behind the Scenes at DCI
- Beyond Formulary Access: Building a Scalable Pharmaceutical Manufacturer Commercial Platform for Direct-to-Consumer and Employer Channels
- Minnesota’s 340B Hospitals Make One Billion More From 340B Than They Spend on Uncompensated Care
- The Top 15 Specialty Pharmacies of 2025: PBM-Affiliated Pharmacies Dominate While Health Systems and Independents Gain Ground
- The Omnichannel Gap: Building the CRM of the Future for Patient Services
- The Hidden Pitfalls of Hub Transitions—and How to Navigate Them
- Mapping the Vertical Integration of Insurers, PBMs, GPOs, Specialty Pharmacies, and Healthcare Services: DCI’s 2026 Update
KevinMD Blog
- An error has occurred; the feed is probably down. Try again later.
Health Populi
- The Blurring of Consumer Brands and Healthcare – HealthConsuming Goes Mainstream, Ipsos Reports
- The Cost of Confusion with U.S. Healthcare – a deja vu of The Temptations’ “Ball of Confusion”
- Gas ‘n Healthcare ‘n Groceries: U.S. Voters’ Cost-of-Living Concerns Will Inspire Them to Vote in the Midterms in the Latest KFF Health Tracking Poll
- Most Brands Speak to Women As If They Are Men: Learning from Hidden Women, Health Marketing Insights from 8th Day
- “Trust is the #1 Public Health Issue” and Health Citizens Live in an “Information Abundant” World That, Counterintuitively, Underpins Divisiveness – the 2026 Edelman Trust Barometer
- “The #1 longevity hack is ‘don’t be poor’” — Kara Swisher is a health economist
- The New Era of DIY Healthcare – The State of Consumer Healthcare is Buoyant, Empowering, and Holistic, from Head to Gut to Wallet
- Americans Are Health Information Seekers — Far Above All, Valuing Info from Providers and Medically-Trained Sources (and lessons for AI in health)
- Past is Prologue as CVS Returns to Its “CVS Pharmacy” Roots – What it Means for Health Consumers and Retail Health (with a nod to Colruyt Group in Belgium)
- Doctors and Consumers in America Agree: Health Care Access and Affordability Rank Top of Mind in March 2026 (surveys from Athenahealth and Gallup)
e-Patients
- SPM at the World Orphan Drug Conference
- Introducing the CHAMP Principal Investigator: Cait DesRoches (Part 2)
- Introducing the CHAMP Principal Investigator: Cait DesRoches (Part 1)
- Everylife Foundation Community Congress Annual Meeting Highlights
- Collaboration is the Best Medicine: Patient-Centered Collaboration Grounded in Caritas®
- Collaboration is the Best Medicine: It’s the Heart of Caregiving
- Collaboration is the Best Medicine: How to Partner with Your Doctor for Better Care
- Collaboration is the Best Medicine: Bridging the Gap in Patient Participation
- Dealing with Medical Uncertainty, Ambiguity, and Frustration
- Collaboration is the Best Medicine: The Time for Participatory Medicine is Now
Enabling Healthy Decisions Blog by www.georgevanantwerp.com is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.
Contact Information
Contact me at gvanantwerp @ mac.com.
Enabling Healthy Decisions 
No comments yet... Be the first to leave a reply!